Linking genetic variation with epigenetic profiles in Sjögren's syndrome

14Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

DNA methylation represents an important regulatory event governing gene expression that is dysregulated in Sjögren's syndrome (SjS) and a number of autoimmune/inflammatory diseases. As disease-associated single-nucleotide polymorphisms (SNPs) have relevance in controlling DNA methylation, 94 non-HLA SjS-SNPs were investigated, among them 57 (60.6%) with widespread effects on 197 individual DNA methylation quantitative trait loci (meQTL) were selected. Typically, these SNPs are intronic, possess an active promoter histone mark, and control cis-meQTLs located around transcription start sites. Interplay is independent of the physical distance between SNPs and meQTLs. Using epigenome-wide association study datasets, SjS-meQTLs were characterized (41 genes and 13 DNA methylation CpG motifs) and for the most part map to a pro-inflammatory cytokine pathway, which is important for the control of DNA methylation in autoimmune diseases. In conclusion, exploring meQTLs represents a valuable tool to predict and investigate downstream effects of genetic factors in complex diseases such as SjS.

Cite

CITATION STYLE

APA

Arvaniti, P., Le Dantec, C., Charras, A., Arleevskaya, M. A., Hedrich, C. M., Zachou, K., … Renaudineau, Y. (2020). Linking genetic variation with epigenetic profiles in Sjögren’s syndrome. Clinical Immunology, 210. https://doi.org/10.1016/j.clim.2019.108314

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free